Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have not seen a single post here other than us since May. There is just no enthusiasm. It may just be you and me till the end here. I would like to see a run before next year's annual meeting and get some people fired up about attending it.
We had the most volume today in months. Was any of that from you?
What most likely occurred was someone dumped about 1,000 shares to take the tax loss before year end.
Lifeloc is better than what we are seeing. It deserves better than this.
We are basically trading near all time lows.
Cannabix (which has nothing, zero, nada, zilch) is still sitting at a market cap of over $40 Million.
No one in management seems to have any concern about the stock price of Lifeloc. We are seeing progress and revenue growth but it has failed to lead to higher stock prices.
I would hope that we don't have to wait until the next quarterly earnings to get a PR from them.
I don't think we are going to see an investor group run it. It is just way too thin. We need news, PR's and media attention.
We did see it make a run in early 2015 and again in early 2017. It just feels like we are overdue and this thing has consolidated for so long that the move should be sustained.
Total shares traded in Lifeloc for the whole year looks like it's not even 25,000. This has to change next year.
And whenever we do get volume like today, it seems like it's all selling.
This has been in the same $2 range for close to two years now.
waynew@lifeloc.com - send him an email with your questions/concerns and I will do the same. There may not be too much else we can do.
Lifeloc urgently hiring for the following positions:
Inside Sales Administrator (Law Enforcement & Corrections Market)
Marketing Intern
International Sales Manager
Material Handler
Laboratory Manager
https://www.indeed.com/jobs?q=lifeloc%20technologies&l&vjk=96edc66584a627cb
I take this as a sign of expansion and expansion is viewed as a good thing for future growth.
I would be interested in knowing how many individuals Cannabix currently employs.
Looks like Lifeloc is hiring a marketing intern (amongst other new jobs) to help with social media exposure.
https://www.indeed.com/jobs?q=lifeloc+technologies&l=
https://www.linkedin.com/jobs/search?keywords=Lifeloc%20Technologies&trk=guest_job_details_jobs-search-bar_search-submit&redirect=false&position=2&pageNum=0¤tJobId=1615892985
I would like to hear what Vern has to say about the happenings at Lifeloc. Do you think he has an interest in seeing this stock trade higher because he should but it doesn't seem like it.
Lifeloc traded a total of 530 shares since it's quarterly earnings report a couple days ago. Something here needs to change. Shareholder value still seems to be non-existent. As shareholders, we have a vote and a say. Maybe it's time for us to exercise that vote and make some management changes.
There is absolutely no way that Cannabix (BLO/BLOZF) should be valued at anywhere near Lifeloc and it’s still more than 3 x
Cannabix 105,124,104 shares x $0.37 = current market cap $38.9 Million
Lifeloc 2,545,116 x $5.99 = current market cap $14.7 Million.
2020 changes this around. Lifeloc should have always been at least 3 x that of Cannabix.
Let’s get to it.
“Likewise, alcohol monitoring is another critical path to growth. Alcohol monitoring is accomplished through our R.A.D.A.R.® (Real-time Alcohol Detection and Reporting) device, which is a tool to supervise offenders as an alternative to incarceration. The R.A.D.A.R. device calls for random alcohol tests, and stores the results for later retrieval by the probation officer, while onboard biometrics automatically verify the identity of the test subject. The second generation R.A.D.A.R. devices are in development with production expected in the first quarter of 2020. R.A.D.A.R. devices and their associated monitoring services are a critical step in moving our business towards a recurring revenue model.”
I consider this RADAR device icing on the cake. Let’s hope they are correct and start production in a couple months. That will be another important revenue stream for 2020 and into the future.
“Real-time drug testing remains Lifeloc’s brightest growth opportunity. Lifeloc and Sandia National Laboratory in cooperation have developed trace analysis technologies for drugs of abuse. Getting rapid, quantitative results for a panel of drugs of abuse, including marijuana, heroin, cocaine and methamphetamine, is a critical tool needed by law enforcement to ensure safety on our roads and in the workplace. We have demonstrated SpinDx to perform trace analysis from liquid and vapor samples in the laboratory. Our work ahead is to complete the conversion of SpinDx from a laboratory test to simple-to-operate devices ready for deployment in the field.”
Real time drug testing is by far the biggest growth opportunity. This is just as big if not bigger than what Taser created. And Taser currently has a market cap of close to $4 Billion.
Our work ahead is to complete the conversion of Spin Dx from a lab test to a simple to operate device - Let’s get to it fellas! Go time.
“It was another strong quarter, both in top line revenue growth and bottom line earnings versus last year,” said CEO Dr. Wayne Willkomm. He added, “We are hopeful for further growth versus last year, with the DOT (Department of Transportation) approval of our newest breathalyzers, which happened in the fourth quarter. These new breathalyzers are packed with features and power that make these top performers while still offering excellent value to our customers. But with the completion of these products, research and development expenses are not expected to drop. We continue to expect research spending to ramp up as we redirect existing resources and even add more resources to deploy against our top priority, which is the development and commercialization of our real-time drug testing, including the marijuana breathalyzer based on the SpinDx lab on a disc detection platform.”
This leads me to believe Lifeloc has a new line of breathalyzers that just received Department of transportation approval and are ready to start producing new revenue streams.
It is also very promising to hear that they are redirecting resources and adding more funding and effort to their top priority which is the SpinDX marijuana breathalyzer.
Fu*k yeah! That’s what I want to hear!
Let’s see if they can pull off submission of the Spin DX platform by the end of the year. Then it’s go time.
“The third quarter performance benefited from the release and shipments of the second generation of our patent protected EasyCal® automated calibration station, as well as increased royalties. This updated calibration station has expanded capabilities to calibrate our entire line of professional breathalyzers as well as RFID (Radio Frequency Identification) registration of calibration standards to further automate the process, representing a further advance of an already unique product.”
It looks like an upgraded calibration station was released in the third quarter and already producing revenues. Increased royalties also seem to be associated with this roll out.
This is progress. I’ll take it!
Key Takeaways:
In October, 2019 we received approval from DOT for our LX9 and LT7 base unit alcohol breathalyzers, which will allow domestic sales of this product to commence in Q4 of 2019.
We have detected delta-9-THC (the primary psychoactive component of marijuana) down to concentrations of 5 nanograms per milliliter in our laboratory. This includes resolving the psychoactive delta-9-THC from its inactive metabolites, an important step in establishing impairment. We completed the upgrade of our base breathalyzer platform in 2019, and we remain committed to combining it with the SpinDx™ technology. Our goal is to use this combination to develop a THC breathalyzer.
We completed upgrading our base breathalyzer product line in Q4 of 2018 and have been submitting the models for local statutory and regulatory approvals throughout 2019. We are nearing completion of work in improving the manufacturability of R.A.D.A.R.® devices, which we expect to launch in Q1 of 2020.
Revenues in the third quarter of 2019 were higher compared to revenues in 2018. We believe changing market conditions together with the domestic launch of our base breathalyzer product line in Q4 may result in further increases in revenues for the remainder of 2019, and with the re-launch of R.A.D.A.R.® in Q1 of 2020, further increases in revenues in 2020.
Highlights from the Quarterly Report:
Total assets of over $9 Million vs. total market cap of $14.7 Million
Revenues of $2.25 Million
Net income of $151,525
Net Income per share of $.06
Net Income of $0.16 per share so far for 2019
On pace for yearly revenues of $9 Million
Quarterly report looks very good at first glance. I’ll dig into this later tonight. Let’s see if the CEO can pull off a submission of the marijuana breathalyzer SpinDX device by the end of the year. That’s what’s really going to make the difference.
According to Lowfloat.com, Lifeloc has the 14th lowest stock float of all US companies on all exchanges including the OTCBB.
https://www.lowfloat.com/all_with_otcbb/
If the true float of 181,067 is taken into account, Lifeloc has the 8th lowest stock float of all US companies.
There are only 3 companies profitable in the top 10 lowest public floats:
EACO
DIT
LCTC
EACO has a market cap of $95 Million
DIT - Amcon Distributing Co has a market cap of $48 Million
LCTC - Lifeloc has a market cap of $12.5 Million
Cannabix (BLO/BLOZF) has a current market cap of over $45 Million and this company has nothing. Zero. Never had a single sale, never had an ounce of revenue, no patents, never profitable, always diluting shares, etc.
Lifeloc has a current market cap of just over $12 Million. Lifeloc is profitable every quarter, is revenue producing, is rolling out new products, never dilutes, etc.
And yet we continue to trade near all time lows and we are valued at one quarter that of Cannabix.
Something needs to change here.
Total volume for the months of September and October in LCTC stock is 1,518 shares. Something needs to change here and I'm open for suggestions. Awareness is non-existent. Management does not care whatsoever where the stock price trades. This is blatantly apparent. It fear it may be up to current shareholders to increase market awareness but it really shouldn't be up to us.
The stock price of LCTC is lower than when Dr. Wilkomm took over as new CEO. He may be a phenomenal engineer but at some point we have to question whether he is capable of running a public company. There really is no concern for shareholders and I have a long list of empty promises. We are basically back near all time lows and without any updates or news releases, we are back to patiently waiting.
I know this company is better than this and as a shareholder, I may have to exercise my voting power and see if we can get a new CEO at the helm.
With the latest news release from Cannabix:
http://www.cannabixtechnologies.com/news-releases.html
I get the feeling Cannabix has just bought themselves some additional time to issue themselves more shares to sell.
BLOZF has nothing folks. No products, no patents, no revenue, no sales. And yet they have a market cap of $52 Million.
"The Company also reports granting 2 million incentive stock options exercisable at $0.80 cents per share for five years to officers and directors and two years for consultants"
Every month or so these guys issue themselves free shares to sell in the open market.
How this company can be valued at more than 3x that of Lifeloc is just absurd.
From the looks of it, there are not many shares between the current price of LCTC and the double digits. A couple hundred shares on the buy side could get us there. It did seem that a decent size buyer was lurking on the bid side today.
We are right back at our $6.00 level of resistance and a push through should get us moving. I did not see too much between $7.00 and $10.00 but we also do not know if the 1,000 share seller is done or just hiding out.
A couple hundred shares on the buy side tomorrow could go a long way and set us up nicely for next week!
In response to your previous post:
This is getting old - agreed. Lifeloc has been dead money for almost 2 years now. No one can argue with that. However, we are finally seeing growth in the quarterly reports.
The company seems to have no interest in letting investors know what is going on. Agreed. I put this on Dr. Wilkomm - the CEO. I have tried my best to get him on board with some updates to no avail.
It's your right to email Mr. Wilkomm and let him know what you think - WayneW@lifeloc.com. Nothing to lose at this point. The more investors start questioning things, the more he may respond with more than just talk.
If we don't get any follow through or continued momentum, this seems to happen every time. A couple hundred shares just brings it right back down. I firmly believe that someone purposely puts pressure on it as soon as it starts to drift higher.
We need some substantial news to really build some momentum in this. A really good earnings report only went so far.
It's a bit disheartening when it takes a thousand shares or more to move this stock a little bit higher, but 100 shares can take it all the way back down in 1 print like it did on Friday.
I could swear that there is someone/something that does not want to see this stock trade higher. Could it be a grudge that Barry Knott still holds? Could it be a market maker that is just not ready to move this thing higher? I don't know but it's had me perplexed for quite some time.
Is there anyone who believes that Lifeloc should not be valued on par with Cannabix?
Shareholder satisfaction and stock price appreciation have never been at the top of their list or even on the list.
All the waiting, posting, researching, and emailing will pay off handsomely at some point. When that point occurs, remains to be an unknown.
The open book in LCTC is very thin pre and post market. It looks like there is not too much stock between the current prices and $60. Each morning and post market when the market maker takes his bids and offers off the book it shows $5.50 x $60.00.
A couple thousand shares could easily take this thing to double digits - No problem. What we don't know is if the 1,000 share seller is still lurking, but any type of good news announcement could take this thing a lot higher.
Here is the detailed patent for the SPECTRAL SIGNATURE DRUG DETECTION:
http://www.patentbuddy.com/Patent/US-20160061807-A1?ft=true
When I asked Dr. Wilkomm if Lifeloc has a patent or any patents pending on the marijuana breathalyzer, he responded, "Attached is a published application for one of the methods that we are working on for the marijuana breathalyzer".
The intellectual property of Lifeloc Technologies includes 16 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category. Additionally, Lifeloc Technologies has registered 7 trademarks with the most popular class being 'Medical apparatus and instruments'.
http://www.patentbuddy.com/pages/patentSearchResult.jsf?assigneeName=LIFELOC%20TECHNOLOGIES%20INC
Current Cannabix/Lifeloc market cap comparison:
Cannabix BLOZF - 104,024,104 shares outstanding x $.56 current price = $58,253,498
Lifeloc LCTC - 2,454,116 share outstanding x $6.25 current price = $15,338,225
Cannabix is valued at 3.8 x that of Lifeloc
Cannabix has no patents, no revenue, no sales, etc. BUT they provide updates! Which leads to hundreds of shareholders that continue to support the company.
That was from back in the middle of April.
I have not had any correspondence from him since then.
We have been shareholders and patient investors in this company for a long time now. If you have questions/concerns/opinions, I suggest you email Dr. Wilkomm and see if you can get some answers.
Here is what I have in regards to the latest feedback from Dr. Wilkomm:
Greetings Dr. Wilkomm. I would like to ask a couple investor questions and pass the information along to friends and family who are also invested in Lifeloc:
In regards to the new breathalyzer platform with features that customers have demanded - You were expecting to begin limited production before the end of 2018 and be running at full scale production during this current quarter. Can you please provide an update on this status? Has this been completed and ready for roll out to those customers?
The upgraded RADAR device was expected to launch in the current quarter - Can you also provide an update on this status? I have noticed that Lifeloc is hiring for a business manager for the RADAR product line. Can I conclude that the upgraded RADAR device has been completed and is ready for roll out?
Has any human testing for the marijuana breathalyzer been commenced? Can we expect any updates on the SpixDX technology and the progress being made?
I would have liked to also see some effort taken in regards to being more active on social media. This was an area that I thought was being worked on but I continue to see minimal effort and lack of investor awareness.
Wayne's response:
Manufacturing did build a small number of units of our new breathalyzer platform before the end of 2018, with a number of build campaigns since then. The product has been sampled and introduced to key distributor customers. The RADAR redesign has been completed with early prototypes in testing now to turn over to manufacturing later this year for market reintroduction. We do not yet have results to report on human testing and we will report updates on the marijuana breathalyzer and SpinDx as soon as we have something solid to report. Yes I agree that we need a higher profile on social media and we have realigned some resources to do that, which I had hoped would have some more activity by now. Time to rattle that cage again.
Here's the email address for the CEO Wayne Wilkomm:
WayneW@lifeloc.com
Have you ever emailed him before? It may help to get a couple investors pushing for some updates.
Here's an article on the science behind the SpinDX technology:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303339/
From the Boulder weekly news:
boulderweekly.com/features/is-the-dawn-of-the-pot-breathalyzer-upon-us/
The sad part is that Boulder is about 15 minutes away from the Lifeloc headquarters/office and there is absolutely no mention of Lifeloc in the article.
Believe it or not, LCTC is at a 52-week high here at $6.25. It would be great to get some additional follow through next week.
I'd love to see smooth sailing and all clear above but we don't know of the 1,000 share seller is finished and out of the way yet.
Here we are again at this utterly important $6.00 price level. This looks like it's a quadruple top going back a year. It's fairly important to keep some momentum up and have some follow through.
The one year chart of LCTC shows a triple top at $6.00 and we have consolidated in this range for over a year. When it decides to break we should see a significant move to the upside. I don't know why we have continued selling pressure at this $6.00 level, but if we can find some volume and buying pressure we should see a significant move higher in the near future.
It is true that we may not have another catalyst to look forward to until the next quarterly report. Let’s pray that we hear something from management about submissions and progress being made.
We are still stuck below that $6.00 price level and we are going to need a significant news release to push past it. The latest quarterly report did not do it which was disappointing and we still have that 1,000 share seller to deal with.
All in due time.
What Happens at Different BAC Levels?
https://www.lifeloc.com/measurement